( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Balaji K. G., Amruth B. and Joga Sasidhar*


MUSCULOSKELTAL DISORDERS are major cause of morbidities and mortality particularly in patients at the extreme of age, and those with pre-existing joint disease or immune suppression. In India, musculoskeletal disorders are responsible for 1.71 billion people have musculoskeletal condition worldwide. Out of these 18-23% is due to osteoarthritis. Drug utilization research is the study of marketing, distribution, prescription and use of drug in a society with special emphasis on the resulting medical, social and economic consequences. Conducting periodic studies of pattern of drug use in a hospital setting is essential to critically analyse the current hospital drug policies and to make recommendations based on various guideline to improve upon the current drug usage pattern. Objectives: To evaluate the prescribing pattern given to patients admitted with musculoskeletal disorders in general medicine and orthopaedic department and to assess the rationality of these prescriptions given in our hospital using WHO core drug prescribing indicators. Methods and Methodology: It was a record based- descriptive study. The study period was about 6 months and the relevant data was collected from in patient records. Result: A total of 162 prescriptions were collected and analysed for demographic characteristics, disease proportion, and prescribing pattern. Males were more (56.79%) compared to females (43.20%). Majority patients belonged to the age group 46-60 years (34.56%). Our most common musculoskeletal disorder found in the study population were osteoarthritis with comorbidities (57.3%). 878 drugs were found in 162 cases among which NSAID’S was mostly given followed by anti- inflammatory. Aceclofenac+ serratiopetidase were most commonly prescribed NSAID’S. Conclusion: Most of the drugs prescribed were included in the WHO essential drug list, India 2021. It is the responsibility of the clinical pharmacist to perform the periodical drug utilization studies in order to know the drug prescribing pattern and also to know the prevalent disease condition at particular point of time.

Keywords: NSAID’s, Drug prescribing pattern, Musculoskeletal disorders.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2023 Issue has been Published, Kindly check it on


    November issue has been successfully launched on 1 November 2023

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database